Validity of diagnostic codes to identify cases of severe acute liver injury in the U.S. Food and Drug Administration's Mini‐Sentinel Distributed Database
- 25 June 2013
- journal article
- research article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 22 (8) , 861-872
Abstract
Purpose: The validity of International Classification of Diseases, Ninth Revision, Clinical Modification (ICD‐9‐CM) codes to identify diagnoses of severe acute liver injury (SALI) is not well known. We examined the positive predictive values (PPVs) of hospital ICD‐9‐CM diagnoses in identifying SALI among health plan members in the Mini‐Sentinel Distributed Database (MSDD) for patients without liver/biliary disease and for those with chronic liver disease (CLD).Methods: We selected random samples of members (149 without liver/biliary disease; 75 with CLD) with a principal hospital diagnosis suggestive of SALI (ICD‐9‐CM 570, 572.2, 572.4, 572.8, 573.3, 573.8, or V42.7) in the MSDD (2009–2010). Medical records were reviewed by hepatologists to confirm SALI events. PPVs of codes and code combinations for confirmed SALI were determined by CLD status.Results: Among 105 members with available records and no liver/biliary disease, SALI was confirmed in 26 (PPV, 24.7%; 95%CI, 16.9−34.1%). Combined hospital diagnoses of acute hepatic necrosis (570) and liver disease sequelae (572.8) had high PPV (100%; 95%CI, 59.0–100%) and identified 7/26 (26.9%) events. Among 46 CLD members with available records, SALI was confirmed in 19 (PPV, 41.3%; 95%CI, 27.0–56.8%). Acute hepatic necrosis (570) or hepatorenal syndrome (572.4) plus any other SALI code had a PPV of 83.3% (95%CI, 51.6–97.9%) and identified 10/19 (52.6%) events.Conclusions: Most individual hospital ICD‐9‐CM diagnoses had low PPV for confirmed SALI events. Select code combinations had high PPV but did not capture all events. Copyright © 2013 John Wiley & Sons, Ltd.Keywords
Funding Information
- U.S. Food and Drug Administration (HHSF223200910006I)
This publication has 22 references indexed in Scilit:
- Drug-Related HepatotoxicityNew England Journal of Medicine, 2006
- Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year PeriodGastroenterology, 2005
- Outcome and prognostic markers in severe drug‐induced liver disease†Hepatology, 2005
- Differences between clinical trials and postmarketing useBritish Journal of Clinical Pharmacology, 2003
- Acute Liver Failure in the United StatesSeminars in Liver Disease, 2003
- Drug-Induced HepatotoxicityNew England Journal of Medicine, 2003
- Safety of Newly Approved DrugsJAMA, 2002
- Drug-Induced Liver DisordersDrug Safety, 2001
- Terbinafine Hepatotoxicity: Case Report and Review of the LiteratureAmerican Journal of Gastroenterology, 1998
- Classification, Etiology, and Considerations of Outcome in Acute Liver FailureSeminars in Liver Disease, 1996